Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control
The timesaving Lyovapor™ L-210 sets new efficiency standards while maintaining reliable and stable cooling performance
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
Advancing clinical pharmacokinetic prediction beyond non-human primate models
New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA
Discover how researchers are using the LUNA-FX7™ automated cell counter to deliver precision and compliance in modern biopharma workflows
Sensitive biophysical characterization techniques have revolutionized drug discovery. Label-free biophysical techniques like bio-layer interferometry (BLI), surface plasmon resonance (SPR) and grating coupled interferometry (GCI) are now key components in drug discovery platforms. In this eBook, we take an in-depth look at each of these biophysical methods and the platforms available.
